Minn. R. agency 164, ch. 6800, CONTROLLED SUBSTANCES, pt. 6800.4230

Current through Register Vol. 49, No. 24, December 9, 2024

Part 6800.4230 - SCHEDULE III CONTROLLED SUBSTANCES

The following items are listed in Schedule III:

A. Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this part.

B. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

	Statutory Name	Some examples of common names, trade names, or names of products which contain a controlled substance
(1)	Amphetamine, Methamphetamine, Methylphenidate and Phenmetrazine, when required by federal law to be labeled with either of the following symbols: C-III or III
(2)	Benzphetamine	Didrex
(3)	Chlorphentermine	Pre-Sate
(4)	Clortermine	Voranil
(5)	Phendimetrazine.	Plegine, Stim-35, Melfiant, Barcarate

C. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

	Statutory Name	Some examples of common names, trade names, or names of products which contain a controlled substance
(1)	Any compound, mixture, or preparation containing:
	(a) Amobarbital;
	(b) Secobarbital;
	(c) Pentobarbital, or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule
(2)	Any suppository dosage form containing:
	(a) Amobarbital;
	(b) Secobarbital;
	(c) Pentobarbital, or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository
(3)	Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically excepted or listed in other schedules	Butabarbital, Vinbarbital, Delvinal, Talbutal, Lotusate, Pentothal, Brevital
(4)	Chlorhexadol
(5)	Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal Food, Drug, and Cosmetic Act
(6)	Ketamine, its salts, isomers, salts of isomers
(7)	Lysergic acid
(8)	Lysergic acid amide
(9)	Methyprylon	Noludar
(10)	Sulfondiethylmethane
(11)	Sulfonethylmethane
(12)	Sulfonmethane
(13)	Tiletamine and zolazepam and any salt thereof	Telazol
(14)	Embutramide.
	D. Nalorphine	Nalline

E. Narcotic Drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows:

(1) Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium: Copavin.

(2) Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts: Cheracol, Elixir, Terpin Hydrate and Codeine, Cosadein, Prunicodeine, Robitussin A.C.

(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts: Ambenyl, Tussend, Hycomine, Tussionex.

(5) Not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts: Cidicol.

(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts: Paregoric, Camphorated Opium Tincture.

(8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

F. Anabolic Steroids.

Clostebol, Chorionic gonadotropin, Dehydrochlor-methyltestosterone, Ethylestrenol, Fluoxymesterone, Human growth hormones, Mesterolone, Methandienone, Methandrostenolone, Methenolone, Methyltestosterone, Nandrolone, Nandrolone phenpropionate, Norethandrolone, Oxandrolone, Oxymesterone, Oxymetholone, Stanozolol, Testosterone propionate, Testosterone-like related compounds

G. Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved product.

H. Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts: Buprenorphine.

Minn. R. agency 164, ch. 6800, CONTROLLED SUBSTANCES, pt. 6800.4230

9 SR 1656; 18 SR 1145; 20 SR 2592; 27 SR 260; 31 SR 1673; 34 SR 1205

Statutory Authority: MS s 151.02; 151.06; 152.02